149 related articles for article (PubMed ID: 325731)
1. In vivo induction of suppressor activity with rabbit antimouse thymocyte serum (ATS) and antigen.
Simpson M; Tuttle S; Gozzo JJ
Transplant Proc; 1977 Mar; 9(1):1041-4. PubMed ID: 325731
[No Abstract] [Full Text] [Related]
2. Whole antilymphocyte serum: a potent safe immunosuppressive agent for intravenous use in man.
Levey RH; Parkman R
Transplant Proc; 1977 Mar; 9(1):1019-22. PubMed ID: 405764
[TBL] [Abstract][Full Text] [Related]
3. Studies on delayed (cellular) hypersensitivity in mice infected with Trichinella spiralis. VII. The effect of ATS injections on the numbers of adult worms recovered after challenge.
Larsh JE; Weatherly NF; Goulson HT; Chaffee EF
J Parasitol; 1972 Dec; 58(6):1052-60. PubMed ID: 4539315
[No Abstract] [Full Text] [Related]
4. Suppressor cell activation by anti-thy 1.2 in NZB/WF1 mice.
Klassen LW; Zarate A; Gelfand MC; Steinberg AD
J Immunol; 1977 Dec; 119(6):2067-72. PubMed ID: 334981
[No Abstract] [Full Text] [Related]
5. Studies on the activity of antithymocyte serum (ATS), particularly on the relation between its anti-inflammatory and immunosuppressive effects.
Gieldanowski J; Blaszczyk B; Szymaniec S; Ludwikowska A
Arch Immunol Ther Exp (Warsz); 1977; 25(3):367-75. PubMed ID: 329800
[TBL] [Abstract][Full Text] [Related]
6. Adoptive transfer of specific unresponsiveness to skin allografts by spleen cells from ALS-treated, marrow-injected mice.
Wood ML; Monaco AP
Transplant Proc; 1979 Mar; 11(1):1023-7. PubMed ID: 377604
[No Abstract] [Full Text] [Related]
7. Prolongation of skin allograft survival in ATS-treated mice by post-transplant injections of species antigenic extracts.
Chutná J; Sládecek M; Holán V; Hasek M
Folia Biol (Praha); 1984; 30(2):109-22. PubMed ID: 6233181
[TBL] [Abstract][Full Text] [Related]
8. Enhanced allograft survival in rhesus monkeys treated with anti-human thymocyte globulin and donor lymphoid cells.
Thomas JM; Carver FM; Burnett CM; Thomas FT
Transplant Proc; 1981 Mar; 13(1 Pt 1):599-602. PubMed ID: 7022896
[No Abstract] [Full Text] [Related]
9. Superiority of soluble antigen extracts and antithymocyte globulin over whole blood and cytotoxic agents in inducing experimental allograft prolongation.
Thomas F; Burke S; Thomas J; Lee HM; Lower RR
Transplant Proc; 1979 Jun; 11(2):1442-3. PubMed ID: 382535
[No Abstract] [Full Text] [Related]
10. Possible manipulations of allograft tolerance by suppressor cells.
Hilgert I; Rieger M; Kristofová H; Vlachov K; Singh SK
Transplant Proc; 1979 Mar; 11(1):887-90. PubMed ID: 88103
[No Abstract] [Full Text] [Related]
11. In vivo induction of specific suppressor lymphocytes to histocompatibility antigens.
Horsburgh T; Wood PJ; Brent L
Transplant Proc; 1981 Mar; 13(1 Pt 1):637-9. PubMed ID: 6455807
[No Abstract] [Full Text] [Related]
12. T cell-derived factor alone or in combination with immunosuppressive drugs augments prolongation of allogeneic skin graft survival in mice receiving donor-specific transfusion.
Gorczynski RM; Boulanger M; Lau C
J Immunol; 1987 May; 138(10):3197-202. PubMed ID: 2952712
[TBL] [Abstract][Full Text] [Related]
13. Antilymphocyte serum: mechanism of action.
Lance EM
Transplant Proc; 1972 Dec; 4(4):473-5. PubMed ID: 4566790
[No Abstract] [Full Text] [Related]
14. Correlation of the in vivo and in vitro activities of antithymocyte sera (ATS) with the immunizing antigen dose.
Végh P; Erdös E; Jánossy T; Petri G
Transplantation; 1978 Jun; 25(6):324-7. PubMed ID: 351891
[TBL] [Abstract][Full Text] [Related]
15. The comparative effectiveness of rabbit anti-mouse thymocyte sera in potentiating the survival of mouse skin or tumour allografts made across the H-2 barrier.
Lai T; Symes MO
Immunology; 1976 Jul; 31(1):21-6. PubMed ID: 800400
[TBL] [Abstract][Full Text] [Related]
16. Cellular cooperation during in vivo anti-hapten antibody responses. III. The helper cell activity of activated thymocytes, of spleen cells treated with anti-theta serum, and of spleen cells from anti-thymocyte serum-treated or adult thymectomized donors.
Janeway CA
J Immunol; 1975 Apr; 114(4):1408-14. PubMed ID: 1078836
[TBL] [Abstract][Full Text] [Related]
17. [Change in mouse peripheral blood during specific and combined suppression of transplantation immunity].
Shatalova IN; Nastoiashchaia NN; Artsimovich NG; Sergel' OS
Dokl Akad Nauk SSSR; 1973; 210(6):1450-2. PubMed ID: 4578780
[No Abstract] [Full Text] [Related]
18. [Effect of cells and serum of donors immunized with recipients' leukocytes on transplantation immunity in rabbits].
Novikov DK; Adamenko GP; Novikova VI
Biull Eksp Biol Med; 1972 Aug; 73(8):58-62. PubMed ID: 4564366
[No Abstract] [Full Text] [Related]
19. Synergistic effects of ATS and passive and active enhancement on heart and skin allografts in rats.
Rowiński WA; Wasowska BA; Ryffa T; Stepkowski S; Dabrowski M; Tilney NL; Olszewski WL
Arch Immunol Ther Exp (Warsz); 1983; 31(6):809-17. PubMed ID: 6378133
[TBL] [Abstract][Full Text] [Related]
20. Induction of tolerance with antilymphocytic serum.
Lance EM; Medawar PB
Transplant Proc; 1969 Mar; 1(1):429-32. PubMed ID: 4944254
[No Abstract] [Full Text] [Related]
[Next] [New Search]
